Skip to content
healthcare.dev

Deferasirox

NDC 69238-1488, Deferasirox, tablet, film coated, from Amneal Pharmaceuticals NY LLC.

Product NDC
69238-1488
Status
Listed
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210727
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1488 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX360 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
69238-1488-36923814880330 TABLET, FILM COATED in 1 BOTTLE (69238-1488-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a7ae9c31-e14f-4cf9-9ab3-850519f1a87c

Use it

Look up 69238-1488 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1488 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69238-1488. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.